Bcl2-Family Inhibitors in Neuroblastoma: Mechanism of Action, Therapy Resistance, and Development of Biomarkers |
Children's Hospital of Philadelphia / Claudia Zapata, MD |
Young Investigator Grants |
2019 |
Pennsylvania |
The Role of PASG in Mediating Epigenetic Change and Outcome in AML.
|
The Johns Hopkins University School of Medicine / Jason Farrar, MD |
Young Investigator Grants |
2007 |
Maryland |
A Developmental Model to Characterize the Epigenetic Origins of the Retinoblastoma Tumor Initiating Cell |
The Johns Hopkins University School of Medicine / Jeffrey Huo, MD, PhD |
Young Investigator Grants |
2014 |
Maryland |
Function and Dependency of NFkB Activity in ZFTA-RELA Fusion Ependymoma |
Baylor College of Medicine / Austin Stuckert, MD |
Young Investigator Grants |
2021 |
Texas |
The TC3 Line, a Zebrafish Model of T-Cell Malignancy
|
Huntsman Cancer Institute / Nathan Meeker, MD |
Young Investigator Grants |
2008 |
Utah |
Targeting the Rac GTPase Pathway to Sabotage RAS Signaling in RAS-mutated Leukemia |
Boston Children's Hospital / Sara Canovas Nunes, PhD |
Young Investigator Grants |
2020 |
Massachusetts |
Identification and Characterization of Pathways Dysregulated by MMSET E1099K Mutation in Relapsed Pediatric Acute Lymphoblastic Leukemia and Their Role in Drug Resistance |
New York University School of Medicine / Joanna Pierro, DO |
Young Investigator Grants |
2017 |
New York |
The Regulation of Hematopoietic Stem Cell Function by Granulocyte-Colony Stimulating Factor |
Washington University / Laura Schuettpelz, MD, PhD |
Young Investigator Grants |
2013 |
Missouri |
Promoter Hypermethylation in MLL-Rearranged Leukemias: Biology and Therapeutic Targeting |
The Johns Hopkins University School of Medicine / Eric Schafer |
Young Investigator Grants |
2010 |
Maryland |
Augmenting Chimeric Antigen Receptor T Cell Induced Epitope Spreading for Pediatric Solid Tumors |
Children's Hospital of Philadelphia / Michael Leibowitz, MD/PhD |
Young Investigator Grants |
2018 |
Pennsylvania |